# FDA Inspection 668221 - Pfizer Canada ULC - March 18, 2010

Source: https://www.keypedia.com/records/fda_inspections/pfizer-canada-ulc/028e238f-b662-4470-94e3-4ea079e1485c
Source feed: FDA_Inspections

> FDA Inspection 668221 for Pfizer Canada ULC on March 18, 2010. Classification: No Action Indicated (NAI).

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 668221
- Company Name: Pfizer Canada ULC
- Inspection Date: 2010-03-18
- Classification: No Action Indicated (NAI)
- Project Area: Drug Quality Assurance
- Product Type: Drugs
- Office Name: Center for Drug Evaluation and Research

## Related Documents

- [FDA Inspection 1220003 - 2023-08-03](https://www.keypedia.com/records/fda_inspections/pfizer-canada-ulc/2491f8ba-a796-4e06-bff8-2c1386eebc2a)
- [FDA Inspection 960393 - 2016-02-12](https://www.keypedia.com/records/fda_inspections/pfizer-canada-ulc/17a72593-11a3-45a6-b5e4-00063fd28ace)
- [FDA Inspection 823543 - 2013-03-07](https://www.keypedia.com/records/fda_inspections/pfizer-canada-ulc/8f6e6d23-880b-4381-aee4-0b8008323007)

Company: https://www.keypedia.com/companies/pfizer-canada-ulc/3beee662-1fd4-4595-9b26-69e120767b2e

Office: https://www.keypedia.com/offices/center-for-drug-evaluation-and-research/cd980d74-1cbf-4226-ba9a-9045324c236c